LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
- Your personalised programme is built around medical care, not willpower.
- No generic diets. No guesswork.
- Just science-backed results and expert support.
Find out if you’re eligible
Constipation is a common side effect experienced by some patients taking Mounjaro (tirzepatide), a dual GIP and GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. This occurs primarily because Mounjaro slows gastric emptying and gastrointestinal motility, which, whilst beneficial for blood glucose control and appetite regulation, can lead to harder, drier stools that are difficult to pass. Understanding why constipation occurs and how to manage it effectively is essential for maintaining treatment adherence and quality of life. This article provides evidence-based strategies for constipation relief, including dietary modifications, lifestyle adjustments, appropriate use of laxatives, and guidance on when to seek medical advice whilst taking Mounjaro.
Quick Answer: Constipation relief with Mounjaro is best achieved through increased dietary fibre (25–30g daily), adequate hydration (1.5–2 litres fluid), regular physical activity, and, if needed, osmotic laxatives such as macrogol under medical guidance.
Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities (though NHS availability for weight management depends on NICE guidance and local commissioning). It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. By mimicking the action of these naturally occurring incretin hormones, Mounjaro helps regulate blood glucose levels, reduces appetite, and promotes weight loss.
The mechanism of action of tirzepatide involves binding to both GIP and GLP-1 receptors, which are found throughout the body, including in the gastrointestinal tract. When activated, these receptors stimulate insulin secretion in response to food intake, suppress glucagon release, and slow gastric emptying—the rate at which food leaves the stomach and enters the small intestine. This delayed gastric emptying contributes significantly to the feeling of fullness and reduced appetite that many patients experience.
However, the same mechanism that helps control blood sugar and supports weight loss can also affect normal digestive processes. Slowed gastrointestinal motility means that food and waste products move more slowly through the digestive system. For many patients, this translates into gastrointestinal side effects, with constipation being a common adverse reaction. Importantly, Mounjaro is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis.
Understanding how Mounjaro interacts with your digestive system is the first step in managing potential bowel-related symptoms effectively and maintaining your overall treatment adherence and quality of life.
LOSE WEIGHT WITH MEDICAL SUPPORT — BUILT FOR MEN
Find out if you’re eligible
Constipation associated with Mounjaro arises primarily from the medication's effect on gastrointestinal motility. By activating GLP-1 receptors in the gut, tirzepatide slows the movement of contents through the stomach and intestines. This prolonged transit time allows more water to be absorbed from the stool in the colon, resulting in harder, drier stools that are more difficult to pass. Clinical trials have shown that gastrointestinal adverse effects, including constipation, occur in a notable proportion of patients, with constipation classified as a common side effect in the Summary of Product Characteristics (SmPC). These effects are particularly noticeable during the initial weeks of treatment or following dose escalations.
Additionally, patients taking Mounjaro often experience reduced appetite and decreased food intake, which is therapeutically beneficial for weight management but can inadvertently contribute to constipation. Lower food volume means less bulk moving through the intestines, and reduced dietary fibre intake—if patients are eating less overall—can further compound the problem. Adequate fibre is essential for maintaining soft, bulky stools that stimulate regular bowel movements.
Other contributing factors may include changes in hydration status. Some patients may not adjust their fluid intake appropriately when eating less, leading to relative dehydration, which exacerbates constipation. Furthermore, lifestyle changes accompanying weight loss efforts, such as altered meal patterns or reduced physical activity during the adjustment period, can influence bowel regularity.
It is important to note that whilst constipation is a recognised side effect, it does not affect all patients equally. Individual responses vary, and some people may experience no bowel changes at all. However, awareness of these mechanisms helps patients and healthcare professionals anticipate and manage symptoms proactively, ensuring that treatment remains tolerable and effective.
Managing constipation whilst taking Mounjaro involves a combination of dietary modifications, lifestyle adjustments, and, when necessary, appropriate use of laxatives. The goal is to support normal bowel function without compromising the therapeutic benefits of the medication.
Increasing dietary fibre is one of the most effective first-line strategies. Aim for at least 25–30 grams of fibre daily from sources such as:
Whole grains (oats, brown rice, wholemeal bread)
Fruits (apples, pears, berries, prunes)
Vegetables (broccoli, carrots, leafy greens)
Pulses and legumes (lentils, chickpeas, beans)
Fibre adds bulk to stools and helps retain water, making them softer and easier to pass. However, increase fibre intake gradually to avoid bloating or gas, and ensure adequate fluid intake alongside.
Hydration is equally critical. Drink 6-8 glasses/cups of fluid daily (approximately 1.5-2 litres), or more if you are physically active or in warm weather. If you have heart or kidney disease, check with your doctor about appropriate fluid intake. Adequate hydration helps keep stools soft and supports overall digestive health.
Regular physical activity stimulates intestinal motility. Even moderate exercise, such as a 30-minute daily walk, can significantly improve bowel regularity. Movement encourages the natural contractions of the intestinal muscles that propel waste through the colon.
If dietary and lifestyle measures are insufficient, over-the-counter laxatives may be considered. Following NICE and BNF guidance, osmotic laxatives (such as macrogol) are typically first-line treatments. Bulk-forming laxatives (such as ispaghula husk) can be effective but require adequate fluid intake and should be used cautiously if fluid intake is limited. Stimulant laxatives (such as senna or bisacodyl) can be used occasionally for short-term relief but should not be relied upon long-term without medical advice. Always consult your GP or pharmacist before starting any laxative, particularly if you have other health conditions or take additional medications.
If constipation persists or worsens despite these measures, discuss with your healthcare professional about potentially adjusting the pace of your Mounjaro dose escalation or temporarily holding at a lower dose until symptoms improve.
Whilst mild constipation can often be managed with self-care measures, certain symptoms warrant prompt medical evaluation. It is important to recognise when constipation may indicate a more serious problem or when professional guidance is needed to adjust your treatment plan.
Contact your GP or call NHS 111 if you experience:
Constipation that is not improving despite trying self-care measures
Abdominal pain or cramping, particularly if it is worsening or accompanied by vomiting
Blood in your stools or black, tarry stools, which may indicate gastrointestinal bleeding
Unexplained weight loss beyond what is expected with Mounjaro treatment
Nausea and vomiting that prevents you from eating or drinking adequately
Signs of bowel obstruction, such as inability to pass stools or wind, severe bloating, or distension
Seek urgent medical attention (call 999) if you experience:
Severe, persistent abdominal pain, especially if radiating to your back (which may indicate pancreatitis)
Severe abdominal pain with vomiting and distension
Symptoms of intestinal obstruction with severe distress
These symptoms may suggest complications that require investigation, such as faecal impaction, bowel obstruction, pancreatitis, or other gastrointestinal conditions. Your doctor may perform a physical examination, review your medication regimen, and consider further investigations if necessary.
Additionally, if constipation is significantly affecting your quality of life or adherence to Mounjaro, discuss this with your healthcare team. They may recommend dose adjustments, additional supportive treatments, or alternative management strategies. It is essential not to discontinue Mounjaro without medical advice, as this could compromise your diabetes control or weight management goals. Open communication with your healthcare professional ensures that side effects are managed effectively whilst maintaining the therapeutic benefits of your treatment.
If you suspect an adverse reaction to Mounjaro, you can report this through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk).
Adopting a holistic approach to bowel health can significantly reduce the risk and severity of constipation whilst taking Mounjaro. These adjustments not only support digestive function but also complement the overall goals of diabetes management and weight loss.
Establish a regular eating pattern. Even though Mounjaro reduces appetite, try to maintain consistent meal times and avoid skipping meals entirely. Regular eating stimulates the gastrocolic reflex—a natural response that promotes bowel movements after food intake. Include a source of fibre at each meal to maintain steady intestinal transit.
Prioritise gut-friendly foods. In addition to fibre-rich options, consider incorporating:
Probiotic foods such as live yoghurt, kefir, sauerkraut, or kimchi, which may support a healthy gut microbiome (though evidence for their effect on constipation is mixed and individual response varies)
Prunes or prune juice, which contain sorbitol, a natural laxative
Flaxseeds or chia seeds, which provide both soluble and insoluble fibre (ensure adequate fluid intake when consuming these and avoid if you have swallowing difficulties or are on fluid restriction)
Limit constipating foods and habits. Reduce intake of processed foods, excessive dairy, and refined carbohydrates, which can slow digestion. Limit caffeine and alcohol, as these can contribute to dehydration.
Develop a consistent bowel routine. Try to use the toilet at the same time each day, ideally after breakfast when the gastrocolic reflex is strongest. Allow adequate time without rushing, and respond promptly to the urge to defecate rather than delaying.
Manage stress effectively. Psychological stress can affect gut motility and exacerbate constipation. Techniques such as mindfulness, yoga, or deep breathing exercises may help support both mental well-being and digestive health.
By integrating these dietary and lifestyle strategies into your daily routine, you can optimise bowel function, minimise constipation, and enhance your overall experience with Mounjaro treatment. Remember that individualised advice from your healthcare team, including a dietitian if available, can provide tailored support based on your specific needs and medical history.
Mounjaro slows gastrointestinal motility by activating GLP-1 receptors in the gut, which delays the movement of food and waste through the digestive system. This prolonged transit time allows more water to be absorbed from stools in the colon, resulting in harder, drier stools that are more difficult to pass.
Osmotic laxatives such as macrogol are typically recommended first-line for constipation associated with Mounjaro, following NICE and BNF guidance. Always consult your GP or pharmacist before starting any laxative, particularly if you have other health conditions or take additional medications.
Contact your GP or call NHS 111 if constipation does not improve with self-care measures, or if you experience abdominal pain, blood in stools, unexplained weight loss, persistent nausea and vomiting, or signs of bowel obstruction. Seek urgent medical attention (call 999) for severe, persistent abdominal pain or symptoms of intestinal obstruction with severe distress.
All medical content on this blog is created based on reputable, evidence-based sources and reviewed regularly for accuracy and relevance. While we strive to keep content up to date with the latest research and clinical guidelines, it is intended for general informational purposes only.
DisclaimerThis content is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional with any medical questions or concerns. Use of the information is at your own risk, and we are not responsible for any consequences resulting from its use.
